HKEX:2552

Hua Medicine (Shanghai) Ltd. Stock Insider Trading

Hong Kong Stock Exchange > Healthcare > Drug Manufacturers—Specialty & Generic

HK$1.61

-0.0500 (-3.01%)

At Close: Jun 20, 2024

Hua Medicine (Shanghai) Ltd. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 2552.HK shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Hua Medicine (Shanghai) Ltd.

Hua Medicine (Shanghai) Ltd. operates as a clinical-stage drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin that is in Phase I clinical trial for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone fo... 2552.HK Profile

Golden Star

Ticker	Date	Change	Price
SRE	Jun 20	1.29%	$75.48
PEG	Jun 20	1.59%	$73.58
DOC	Jun 20	1.39%	$19.38
FRT	Jun 20	0.0792%	$101.00
BRK-A	Jun 20	1.11%	$617,249.90
ANGL	Jun 20	0.0350%	$28.57
V	Jun 18	0.98%	$273.62
EPD	Jun 18	2.40%	$28.30
USFD	Jun 18	2.30%	$53.14
UFPT	Jun 18	2.69%	$253.79

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In